Availability of Human Papillomavirus Vaccine at Medical Practices in an Area with Elevated Rates of Cervical Cancer

Journal of Adolescent Health

Volumn 45, Issue 5, 2009, Pages 438-444

  Gottlieb, Sami L ^a   Brewer, Noel T ^b   Smith, Jennifer S ^b   Keating, Katie M ^b   Markowitz, Lauri E ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b The University of North Carolina at Chapel Hill   (United States)

Author keywords

Adolescent health services; HPV vaccines; Human papillomavirus

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; AFRICAN AMERICAN; ARTICLE; CHILD; DRUG COST; FEMALE; GENERAL PRACTICE; HEALTH CARE AVAILABILITY; HEALTH SURVEY; HUMAN; INTERVIEW; MEDICAL PRACTICE; MEDICAL STAFF; OUTPATIENT CARE; PRIORITY JOURNAL; REIMBURSEMENT; SCHOOL CHILD; UNITED STATES; UTERINE CERVIX CANCER;

ADOLESCENT; ADOLESCENT HEALTH SERVICES; FEMALE; HEALTH CARE SURVEYS; HEALTH FACILITIES; HUMANS; MEDICINE; NORTH CAROLINA; PAPILLOMAVIRUS VACCINES; UTERINE CERVICAL NEOPLASMS;

EID: 70349862870     PISSN: 1054139X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jadohealth.2009.05.013     Document Type: Article

References (26)

1. Garland S.M., Hernandez-Avila M., Wheeler C.M., et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med 356 19 (2007) 1928-1943
2. Villa L.L., Costa R.L., Petta C.A., et al. High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up. Br J Cancer 95 11 (2006) 1459-1466
3. Press Release: CDC's Advisory Committee Recommends Human Papillomavirus Vaccination, June 29, 2006. Available at: http://www.cdc.gov/od/oc/media/pressrel/r060629.htm. Accessed March 3, 2009.
4. Markowitz L.E., Dunne E.F., Saraiya M., et al. Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 56 RR-2 (2007) 1-24
5. National Cancer Institute. SEER Stat Fact Sheets-Cancer of the Cervix Uteri. Available at: http://seer.cancer.gov/statfacts/html/cervix.html. Accessed March 3, 2009.
6. Gottlieb S.L., Brewer N.T., Sternberg M.R., et al. Human papillomavirus vaccine initiation in an area with elevated rates of cervical cancer. J Adolesc Health 45 (2009) 430-437
7. National Cancer Institute. SEER Cancer Statistics-Fast Stats. Available at: http://seer.cancer.gov/faststats/selections.php#Output. Accessed March 3, 2009.
8. Santoli J.M., Rodewald L.E., Maes E.F., et al. Vaccines for Children program, United States, 1997. Pediatrics 104 2 (1999) e15
9. Schaffer S.J., Szilagyi P.G., Shone L.P., et al. Physician perspectives regarding pneumococcal conjugate vaccine. Pediatrics 110 6 (2002) e68
10. Freed G.L., Freeman V.A., Clark S.J., et al. Pediatrician and family physician agreement with and adoption of universal hepatitis B immunization. J Fam Pract 42 6 (1996) 587-592
11. Davis M.M., Ndiaye S.M., Freed G.L., and Clark S.J. One-year uptake of pneumococcal conjugate vaccine: a national survey of family physicians and pediatricians. J Am Board Fam Pract 16 5 (2003) 363-371
12. Committee on Adolescent Health Care. ACOG Working Group on Immunization. ACOG Committee Opinion No. 344: Human papillomavirus vaccination. Obstet Gynecol 108 3, Pt 1 (2006) 699-705
13. Rand C.M., Shone L.P., Albertin C., et al. National health care visit patterns of adolescents: implications for delivery of new adolescent vaccines. Arch Pediatr Adolesc Med 161 3 (2007) 252-259
14. Davis M.M., Ndiaye S.M., Freed G.L., et al. Influence of insurance status and vaccine cost on physicians' administration of pneumococcal conjugate vaccine. Pediatrics 112 3, Pt 1 (2003) 521-526
15. Kempe A., Daley M.F., Parashar U.D., et al. Will pediatricians adopt the new rotavirus vaccine?. Pediatrics 119 1 (2007) 1-10
16. Lee G.M., Santoli J.M., Hannan C., et al. Gaps in vaccine financing for underinsured children in the United States. JAMA 298 6 (2007) 638-643
17. Keating K.M., Brewer N.T., Gottlieb S.L., et al. Potential barriers to HPV vaccine provision among medical practices in an area with high rates of cervical cancer. J Adolesc Health 43 4 Suppl (2008) S61-S67
18. McInerny T.K., Cull W.L., and Yudkowsky B.K. Physician reimbursement levels and adherence to American Academy of Pediatrics well-visit and immunization recommendations. Pediatrics 115 4 (2005) 833-838
19. Dempsey A.F., and Davis M.M. Overcoming barriers to adherence to HPV vaccination recommendations. Am J Manag Care 12 17 Suppl (2006) S484-S491
20. Glazner J.E., Beatty B.L., Pearson K.A., and Berman S. The cost of giving childhood vaccinations: differences among provider types. Pediatrics 113 6 (2004) 1582-1587
21. Freed G.L., Cowan A.E., Gregory S., and Clark S.J. Variation in provider vaccine purchase prices and payer reimbursement. Pediatrics 122 6 (2008) 1325-1331
22. Jacobson V.J., and Szilagyi P. Patient reminder and patient recall systems to improve immunization rates. Cochrane Database Syst Rev 3 (2005) CD003941
23. Centers for Disease Control and Prevention. Immunization Strategies for Healthcare Practices and Providers. Available at: http://www.cdc.gov/vaccines/pubs/pinkbook/downloads/strat-508.pdf. Accessed July 7, 2009.
24. Stone E.G., Morton S.C., Hulscher M.E., et al. Interventions that increase use of adult immunization and cancer screening services: a meta-analysis. Ann Intern Med 136 9 (2002) 641-651
25. Daley M.F., Liddon N., Crane L.A., et al. A national survey of pediatrician knowledge and attitudes regarding human papillomavirus vaccination. Pediatrics 118 6 (2006) 2280-2289
26. Middleman A.B. Adolescent immunizations: policies to provide a shot in the arm for adolescents. J Adolesc Health 41 2 (2007) 109-118